Tekmira will resume safety study of Ebola drug within weeks

April 10, 2015 4:50 PM

7 0

Tekmira will resume safety study of Ebola drug within weeks

Canadian drugmaker Tekmira Pharmaceuticals said Friday it will restart a study of an experimental Ebola treatment in the coming weeks.

The company said the Food and Drug Administration will allow it to administer the drug, called TKM-Ebola, to a small number of healthy people once a day for a one-week safety trial. Some patients in the trial will receive TKM-Ebola and the rest will get a placebo injection.

Read more

To category page

Loading...